Evidence map›Paper›PMID 30052626›Full record

ArticlePLoS biology2018

HIV induces synaptic hyperexcitation via cGMP-dependent protein kinase II activation in the FIV infection model.

Keira Sztukowski, Kaila Nip, Paige N Ostwald, Matheus F Sathler, Julianna L Sun, Jiayi Shou, Emily T Jorgensen, Travis E Brown, John H Elder, Craig Miller and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The autism-associated loss of δ-catenin functions disrupts social behavior.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Keira SztukowskiCollege of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
Kaila NipCellular and Molecular Biology Graduate Program, Colorado State University, Fort Collins, Colorado, United States of America.
Paige N OstwaldCellular and Molecular Biology Graduate Program, Colorado State University, Fort Collins, Colorado, United States of America.
Matheus F SathlerDepartment of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
Julianna L SunDepartment of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
Jiayi ShouDepartment of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
Emily T JorgensenPharmaceutical Science and Neuroscience, University of Wyoming, Laramie, Wyoming, United States of America.
Travis E BrownPharmaceutical Science and Neuroscience, University of Wyoming, Laramie, Wyoming, United States of America.
John H ElderDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
Craig MillerDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.
Franz HofmannTechnical University of Munich, Munich, Germany.
Sue VandeWoudeDepartment of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.
Seonil KimCellular and Molecular Biology Graduate Program, Colorado State University, Fort Collins, Colorado, United States of America.ORCID 0000-0002-1217-8784
Colorado State University · USUniversity of Wyoming · USScripps Research Institute · USTechnical University of Munich · DE

Funding

MOLECULAR CHARACTERIZATION OF FIVR01AI025825 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ELDER, JOHN H · 1987 to 2015
$6.0M
Perineuronal nets and cocaine-associated memoriesR01DA040965 · NIDA · WASHINGTON STATE UNIVERSITY · PI BROWN, TRAVIS EUGENE, SORG, BARBARA A · 2016 to 2020
$2.0M
Veterinary Scholars Summer Research ProgramT35OD015130 · OD · COLORADO STATE UNIVERSITY · PI ZABEL, MARK D · 2012 to 2021
$654k
FIV as a model to study pathogenesis and treatment of HIV-induced oral disease in childrenF32DE026679 · NIDCR · COLORADO STATE UNIVERSITY · PI MILLER, CRAIG ANDREW · 2016 to 2017
$105k
NIAID NIH HHS R01 AI025825NIDA NIH HHS R01 DA040965NIDCR NIH HHS F32 DE026679NIH HHS T35 OD015130
6 · The paper itself

Abstract

Over half of individuals infected with human immunodeficiency virus (HIV) suffer from HIV-associated neurocognitive disorders (HANDs), yet the molecular mechanisms leading to neuronal dysfunction are poorly understood. Feline immunodeficiency virus (FIV) naturally infects cats and shares its structure, cell tropism, and pathology with HIV, including wide-ranging neurological deficits. We employ FIV as a model to elucidate the molecular pathways underlying HIV-induced neuronal dysfunction, in particular, synaptic alteration. Among HIV-induced neuron-damaging products, HIV envelope glycoprotein gp120 triggers elevation of intracellular Ca2+ activity in neurons, stimulating various pathways to damage synaptic functions. We quantify neuronal Ca2+ activity using intracellular Ca2+ imaging in cultured hippocampal neurons and confirm that FIV envelope glycoprotein gp95 also elevates neuronal Ca2+ activity. In addition, we reveal that gp95 interacts with the chemokine receptor, CXCR4, and facilitates the release of intracellular Ca2+ by the activation of the endoplasmic reticulum (ER)-associated Ca2+ channels, inositol triphosphate receptors (IP3Rs), and synaptic NMDA receptors (NMDARs), similar to HIV gp120. This suggests that HIV gp120 and FIV gp95 share a core pathological process in neurons. Significantly, gp95's stimulation of NMDARs activates cGMP-dependent protein kinase II (cGKII) through the activation of the neuronal nitric oxide synthase (nNOS)-cGMP pathway, which increases Ca2+ release from the ER and promotes surface expression of AMPA receptors, leading to an increase in synaptic activity. Moreover, we culture feline hippocampal neurons and confirm that gp95-induced neuronal Ca2+ overactivation is mediated by CXCR4 and cGKII. Finally, cGKII activation is also required for HIV gp120-induced Ca2+ hyperactivation. These results thus provide a novel neurobiological mechanism of cGKII-mediated synaptic hyperexcitation in HAND.

Indexed as

AnimalsCalciumCatsChemokine CXCL12Cyclic GMP-Dependent Protein Kinase Type IIDisease Models, AnimalEnzyme ActivationFeline Acquired Immunodeficiency SyndromeHippocampusHIV-1HIV Envelope Protein gp120Immunodeficiency Virus, FelineInositol 1,4,5-Trisphosphate ReceptorsMiceModels, BiologicalNeuronsCalciumChemokine CXCL12Cyclic GMP-Dependent Protein Kinase Type IIHIV Envelope Protein gp120Inositol 1,4,5-Trisphosphate ReceptorsNitric Oxide Synthase Type IProtein SubunitsReceptors, AMPAViral Proteins

Identifiers

PMID30052626
PMCPMC6082575
OpenAlexW2883548470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.